These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 21671019

  • 1. Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis.
    Wu XY, Chen MB, Wang LQ, Xu Y, Tan Y, Shen WX.
    Breast Cancer Res Treat; 2011 Nov; 130(1):357-8. PubMed ID: 21671019
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk.
    Yang TF, Guo L, Wang Q.
    Asian Pac J Cancer Prev; 2014 Nov; 15(3):1263-7. PubMed ID: 24606450
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk.
    Lei H, Sjöberg-Margolin S, Salahshor S, Werelius B, Jandáková E, Hemminki K, Lindblom A, Vorechovský I.
    Int J Cancer; 2002 Mar 10; 98(2):199-204. PubMed ID: 11857408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Breast Cancer.
    Hsiao CL, Liu LC, Shih TC, Lai YL, Hsu SW, Wang HC, Pan SY, Shen TC, Tsai CW, Chang WS, Su CH, Way TD, Chung JG, Bau DT.
    In Vivo; 2018 Mar 10; 32(3):487-491. PubMed ID: 29695550
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Current evidence on the relationships among five polymorphisms in the matrix metalloproteinases genes and prostate cancer risk.
    Gui J, Zhou H, Li S, Chen A, Liu Q, Zhu L, Mi Y.
    Sci Rep; 2024 May 18; 14(1):11355. PubMed ID: 38762659
    [Abstract] [Full Text] [Related]

  • 17. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
    Dos Reis ST, Pontes J, Villanova FE, Borra PM, Antunes AA, Dall'oglio MF, Srougi M, Leite KR.
    J Urol; 2009 May 18; 181(5):2320-5. PubMed ID: 19303106
    [Abstract] [Full Text] [Related]

  • 18. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S, Wang Y, Zhang JH, Jin X, Fang SM, Li Y.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep 18; 40(9):601-4. PubMed ID: 16202315
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
    Nasr HB, Mestiri S, Chahed K, Bouaouina N, Gabbouj S, Jalbout M, Chouchane L.
    Clin Chim Acta; 2007 Sep 18; 384(1-2):57-63. PubMed ID: 17599818
    [Abstract] [Full Text] [Related]

  • 20. Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse.
    Ferrari MM, Rossi G, Biondi ML, Viganò P, Dell'utri C, Meschia M.
    Arch Gynecol Obstet; 2012 Jun 18; 285(6):1581-6. PubMed ID: 22210296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.